SYNG Pharmaceuticals

SYNG Pharmaceuticals (SYNG Pharma), is a pre-clinical stage Biotechnology company dedicated to developing new ‘first-in-class’ diagnostic accompanied therapeutics for endometriosis and castration resistant prostate cancer.

Focus area
Oncology
Graduation date
02/28/2018
Commencement date
06/01/2016